Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares OutstandingShares Outstanding
Ratios

Bioceres Crop Solutions (BIOX) Non-Current Receivables (2017 - 2025)

Bioceres Crop Solutions' Non-Current Receivables history spans 9 years, with the latest figure at $23.7 million for Q2 2025.

  • On a quarterly basis, Non-Current Receivables rose 217188.36% to $23.7 million in Q2 2025 year-over-year; TTM through Jun 2025 was $23.7 million, a 217188.36% increase, with the full-year FY2025 number at $23.7 million, up 217188.36% from a year prior.
  • Non-Current Receivables hit $23.7 million in Q2 2025 for Bioceres Crop Solutions, up from $10889.0 in the prior quarter.
  • Over the last five years, Non-Current Receivables for BIOX hit a ceiling of $23.7 million in Q2 2025 and a floor of $10889.0 in Q2 2024.
  • Historically, Non-Current Receivables has averaged $5.2 million across 5 years, with a median of $16286.0 in 2023.
  • Biggest five-year swings in Non-Current Receivables: plummeted 99.28% in 2023 and later soared 217188.36% in 2025.
  • Tracing BIOX's Non-Current Receivables over 5 years: stood at $12589.0 in 2021, then skyrocketed by 17806.1% to $2.3 million in 2022, then plummeted by 99.28% to $16286.0 in 2023, then tumbled by 33.14% to $10889.0 in 2024, then soared by 217188.36% to $23.7 million in 2025.
  • Business Quant data shows Non-Current Receivables for BIOX at $23.7 million in Q2 2025, $10889.0 in Q2 2024, and $16286.0 in Q2 2023.